Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.

Green A, Kaul A, O'Shea J, Sharma E, Bennett L, Mullings EL, Munafò MR, Nutt DJ, Melichar JK, Donaldson LF.

J Psychopharmacol. 2013 Mar;27(3):265-75. doi: 10.1177/0269881112472567. Epub 2013 Jan 29.

PMID:
23364815
2.

Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.

3.

Severe opioid withdrawal syndrome after a single dose of nalmefene.

Donnerstag N, Schneider T, Lüthi A, Taegtmeyer A, Raetz Bravo A, Mehlig A.

Eur J Clin Pharmacol. 2015 Aug;71(8):1025-6. doi: 10.1007/s00228-015-1884-1. Epub 2015 Jun 7. No abstract available.

PMID:
26050241
4.

Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).

Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP; NEPOD Research Group.

Addiction. 2004 Apr;99(4):450-60. Erratum in: Addiction. 2005 Jan;100(1):139.

PMID:
15049745
5.

Opioid-dependent error processing.

Fellows-Smith J.

J Opioid Manag. 2011 Nov-Dec;7(6):443-9. Erratum in: J Opioid Manag. 2012 May-Jun;8(3):141.

PMID:
22320026
7.

Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.

Jhugroo A, Ellayah D, Norman A, Hulse G.

J Psychopharmacol. 2014 Aug;28(8):800-3. doi: 10.1177/0269881114528592. Epub 2014 Apr 2.

PMID:
24695742
8.

Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients.

Mysels DJ, Vosburg SK, Benga I, Levin FR, Sullivan MA.

J Opioid Manag. 2011 Jan-Feb;7(1):47-53.

9.

A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.

Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC.

J Pharmacol Exp Ther. 2014 Feb;348(2):217-26. doi: 10.1124/jpet.113.209478. Epub 2013 Nov 13.

10.
11.

The diverse clinical uses of opioid receptor drugs.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 May;48(5):11-4. doi: 10.3928/02793695-20100408-01.

PMID:
20415289
12.

[Naltrexone and opiate substitutive treatment].

Dupouy J, Poutrain JC, Lapeyre-Mestre M.

Therapie. 2011 Nov-Dec;66(6):549-52. doi: 10.2515/therapie/2011072. Epub 2011 Dec 21. French. No abstract available.

PMID:
22691393
13.

The effect of naltrexone on taste detection and recognition threshold.

Arbisi PA, Billington CJ, Levine AS.

Appetite. 1999 Apr;32(2):241-9.

PMID:
10097028
14.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

15.

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.

Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.

Pharmacopsychiatry. 2002 Sep;35(5):159-64.

PMID:
12237786
16.

Blocking endogenous opioids during development--do we understand the consequences?

White J.

Addiction. 2013 Feb;108(2):251-2. doi: 10.1111/j.1360-0443.2012.03914.x. No abstract available.

PMID:
23331878
17.

The science and practice of medication-assisted treatments for opioid dependence.

Pecoraro A, Ma M, Woody GE.

Subst Use Misuse. 2012 Jun-Jul;47(8-9):1026-40. doi: 10.3109/10826084.2012.663292.

PMID:
22676570
18.

Heroin anticraving medications: a systematic review.

Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.

Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Epub 2010 Oct 19. Review.

PMID:
20955107
19.

Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Sohler NL, Weiss L, Egan JE, López CM, Favaro J, Cordero R, Cunningham CO.

J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.

20.

Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.

Pélissier F, Rougé Bugat ME, Nubukpo P, Franchitto N.

J Clin Psychopharmacol. 2016 Feb;36(1):100-3. doi: 10.1097/JCP.0000000000000448. No abstract available.

PMID:
26658085

Supplemental Content

Support Center